AltMountain

NSC Biotech Opportunities QP Fund, LLC

Status: no Form D since Mar 2018. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

NSC Biotech Opportunities QP Fund, LLC is a private investment fund based in New York, New York. According to its most recent Form D, filed Mar 12, 2018, it has sold $5,442,000 of interests to 29 investors since its first sale in Feb 2018. The minimum investment it accepts from an outside investor is $100,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Michael Mullen; Glenn Worman; NSC Biotech Opportunities Management Associates, LLC.

Total raised
$5,442,000Cumulative sales reported on Form D
Investors
29
First sale
Feb 28, 2018
Minimum investment
$100,000
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Michael Mullen; Glenn Worman; NSC Biotech Opportunities Management Associates, LLC
Latest Form D
Mar 12, 2018

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​​‌⁠

Vehicles of this fund (2)

Legal name on Form DSEC CIKLocation reportedTotal raisedInvestorsMinimumLatest Form D
NSC Biotech Opportunities QP Fund, LLC (main vehicle on this page)1733793New York, New York$5,442,00029$100,000Mar 12, 2018
NSC Biotech Opportunities Fund, LLC1733796New York, New York$1,075,00011$100,000Mar 12, 2018

Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 2 filings carry the same name apart from such vehicle words or a series letter and report the same location or the same adviser, so AltMountain shows them on one page; the details above are those of NSC Biotech Opportunities QP Fund, LLC, the vehicle reporting the most raised. Each row is that vehicle's own filing, exactly as filed. The amounts should not be added together, because a feeder's money can also be counted in its master fund. Grouped by AltMountain from the filings; not confirmed by the fund. The CIK links open each vehicle's filings on SEC.gov. Source: SEC Form D filings.

Questions about NSC Biotech Opportunities QP Fund, LLC

What is the minimum investment for NSC Biotech Opportunities QP Fund, LLC?

According to its latest Form D, filed Mar 12, 2018, the minimum investment NSC Biotech Opportunities QP Fund, LLC accepts from an outside investor is $100,000.

Who can invest in NSC Biotech Opportunities QP Fund, LLC?

NSC Biotech Opportunities QP Fund, LLC is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has NSC Biotech Opportunities QP Fund, LLC raised?

NSC Biotech Opportunities QP Fund, LLC reports $5,442,000 sold from 29 investors on its Form D filed Mar 12, 2018. This is cumulative sales since the offering began, not current assets or performance.

Where is NSC Biotech Opportunities QP Fund, LLC based?

NSC Biotech Opportunities QP Fund, LLC is based in New York, New York.

When did NSC Biotech Opportunities QP Fund, LLC launch?

NSC Biotech Opportunities QP Fund, LLC reports its first sale in Feb 2018.

Size compared with every private investment fund

Raised more than 42% of the 2,862 private investment funds based in New York, and more than 33% of all 10,363 that report sales.

Other programs from NSC Biotech Opportunities Management Associates, LLC

All 2 funds from this sponsor

More private investment funds in New York

Similar-size private investment funds in New York

All private investment funds in New York